Johnson & Johnson Posts Higher Quarterly Sales, Raises 2023 Outlook

Legal charges, Kenvue spinoff weigh on earnings

Johnson & Johnson, based in New Brunswick, N.J., is in the process of spinning off its consumer-health business into a new company.Photo: Mark Kauzlarich/Bloomberg News

Johnson & Johnson raised its full-year sales and earnings outlook after revenue rose 5.6% in the first quarter, lifted by demand for everything from Tylenol and Imodium to the company’s pharmaceutical products.

The New Brunswick, N.J., healthcare-products company also said Tuesday that first-quarter earnings were wiped out by a $6.9 billion charge tied to litigation and other costs from its Covid-19 vaccine commitments. Costs tied to the separation of its consumer-health business also weighed on results. 

What's News

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue reading your article with
a WSJ subscription

Subscribe Now

Already a subscriber? Sign In

Sponsored Offers
  • adidas:
    adidas Promo Code - Up to 50% Off 3-Stripe Favorites
  • Nike:
    Nike promo code: Members save up to 20% on select styles
  • American Eagle Outfitters:
    15% off American Eagle promo code
  • Foot Locker:
    Save Up to $100 off military discount - Foot Locker Coupon Code
  • Finish Line:
    $10 Finish Line Coupon with text signup
  • ASOS:
    Take 20% Off w/ ASOS Promo Code